Tereza Moore, PhD

Dr. Moore received her PhD in Molecular and Cell Biology from UC Berkeley and did her postdoctorate fellowship and clinical biochemical genetics training at Stanford University. As a clinical biochemical genetics fellow, she gained expertise in diagnosing and follow-up testing for patients with mitochondrial disease. Following her training, she continued her research in the biochemical genetics lab at Stanford investigating new paths in diagnosis and therapy of mitochondrial-associated diseases, including Parkinson’s disease.  She has worked in the field of mitochondrial biology for over 15 years and her scientific career has been focused on understanding the metabolic consequences of mitochondrial dysfunction, characterizing biomarkers for use in diagnosis and therapeutic monitoring, and developing therapies that mitigate the negative consequences of mitochondrial dysfunction. Her contribution to science includes developing mass spectrometry assays to measure metabolic intermediates, identifying metabolic signatures in patient samples, and discovering a promising therapeutic target for treating disorders with mitochondrial dysfunction.